Mozart Therapeutics

company

About

The company intended to focus on developing novel immune engagers.

Details

Last Funding Type
Series A
Last Funding Money Raised
$55M
Industries
Biotechnology
Founded date
Jan 1, 2020
Operating Status
Active

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$55M
Mozart Therapeutics has raised a total of $55M in funding over 2 rounds. Their latest funding was raised on Oct 26, 2021 from a Series A round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Oct 26, 2021 Series A $55M 1 ARCH Venture Partners Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Mozart Therapeutics is funded by 1 investors. ARCH Venture Partners are the most recent investors.
Investor Name Lead Investor Funding Round
ARCH Venture Partners Yes Series A